These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2001979)

  • 21. 'Beta-lactams' as beta-lactamase inhibitors.
    Cole M
    Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacterial resistance to beta-lactam antibiotics].
    Roy C
    Med Clin (Barc); 1983 Sep; 81(7):299-301. PubMed ID: 6606092
    [No Abstract]   [Full Text] [Related]  

  • 23. One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams.
    King DT; Sobhanifar S; Strynadka NC
    Protein Sci; 2016 Apr; 25(4):787-803. PubMed ID: 26813250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LL-AF283 antibiotics, cyclic biphenyl peptides.
    Chang CC; Morton GO; James JC; Siegel MM; Kuck NA; Testa RT; Borders DB
    J Antibiot (Tokyo); 1991 Jun; 44(6):674-7. PubMed ID: 2071492
    [No Abstract]   [Full Text] [Related]  

  • 25. Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics.
    Chen L; Yuan Y; Helm JS; Hu Y; Rew Y; Shin D; Boger DL; Walker S
    J Am Chem Soc; 2004 Jun; 126(24):7462-3. PubMed ID: 15198592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological properties of 1-oxapenems.
    Murakami M; Aoki T; Matsuura M; Nagata W
    J Antibiot (Tokyo); 1990 Nov; 43(11):1441-9. PubMed ID: 2272920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors.
    Coleman K
    Curr Opin Microbiol; 2011 Oct; 14(5):550-5. PubMed ID: 21840248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of gramicidin S-inspired cyclic mixed α/β-peptides.
    van der Knaap M; Basalan F; van de Mei HC; Busscher HJ; van der Marel GA; Overkleeft HS; Overhand M
    Chem Biodivers; 2012 Nov; 9(11):2494-506. PubMed ID: 23161631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-lactamases as the main resistance factor to penicillin-related antibiotics.
    Frère JM; Joris B
    Ann Biol Clin (Paris); 1988; 46(2):151-6. PubMed ID: 3260085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the chemistry of beta-lactam compounds as selected active-site serine beta-lactamase inhibitors.
    Mascaretti OA; Danelon GO; Laborde M; Mata EG; Setti EL
    Curr Pharm Des; 1999 Nov; 5(11):939-53. PubMed ID: 10539998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activity of some monocyclic- and bicyclic beta-lactams with specified functional groups.
    Hwu JR; Ethiraj KS; Hakimelahi GH
    Mini Rev Med Chem; 2003 Jun; 3(4):305-13. PubMed ID: 12678824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance.
    Athanassiou G; Michaleas S; Lada-Chitiroglou E; Tsitsa T; Antoniadou-Vyza E
    J Pharm Pharmacol; 2003 Mar; 55(3):291-300. PubMed ID: 12724033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemistry. Rings of destruction.
    Ganz T
    Nature; 2001 Jul; 412(6845):392-3. PubMed ID: 11473296
    [No Abstract]   [Full Text] [Related]  

  • 37. [Future development of antibiotics. 1. beta-Lactam antibiotics].
    Sawai T
    Nihon Rinsho; 1984 Mar; 42(3):524-30. PubMed ID: 6471449
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-lactam resistance in anaerobic bacteria: a review.
    Hedberg M; Nord CE
    J Chemother; 1996 Feb; 8(1):3-16. PubMed ID: 8835102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A concise synthesis of a β-lactamase inhibitor.
    Mangion IK; Ruck RT; Rivera N; Huffman MA; Shevlin M
    Org Lett; 2011 Oct; 13(20):5480-3. PubMed ID: 21916523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanisms of resistance to beta-lactam inhibitors of beta-lactamases].
    Blázquez J
    Rev Esp Quimioter; 1998 Dec; 11(4):368-9. PubMed ID: 10336318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.